Adults with obesity using a GLP-1 have a similar risk for obesity-related cancers as those who undergo bariatric surgery, ...

Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...

A one-unit increase in cholangioscopy procedures was linked to a 24% increase in subsequent cholangiocarcinoma diagnoses the ...

Creators of the OpenEvidence AI data aggregation tool have partnered with the New England Journal of Medicine to provide 35 ...

Drug and alcohol references in popular music not only correlate with use, but they also provide opportunities for engaging young patients, according to a presentation at the American Psychiatric ...

Although estate planning is often “on the radar” for physicians, too often they ignore another important planning area — incapacity planning. A well-designed and effectively implemented incapacity ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

It is a challenging time to be a women’s health care provider, but there are ways physicians can reclaim their power while ...

On Thursday, the “Make America Healthy Again” commission released its first report on the potential contributors of chronic ...

A subretinal injection of ATSN-201 gene therapy demonstrated promising results in patients with X-linked retinoschisis in a ...